Results 181 to 190 of about 213,692 (300)

Human vaccines and immunotherapeutics: News January 2024

Human Vaccines & Immunotherapeutics
Ronald Ellis, Adam Weiss
doaj   +1 more source

Who owns your doctor? A decade of trends in physician practice ownership in dermatology and gastroenterology. [PDF]

Health Aff Sch
Staiger B, Li B, Huang R, La Forgia A.
europepmc   +1 more source

Translating whole‐genome doubling into precision medicine in cancer

Molecular Oncology, EarlyView.
Whole‐genome doubling creates a WGD‐positive tumor state characterized by persistent chromosomal instability, karyotypic diversification, and cellular stress. These same biological pressures drive aggressive tumor evolution while exposing therapeutic vulnerabilities, providing a rationale for WGD‐informed precision medicine. Whole‐genome doubling (WGD)
Sejung Lee, Junghyeok Lim, Jinhyuk Bhin
wiley   +1 more source

Human vaccines and immunotherapeutics: News February 2025

Human Vaccines & Immunotherapeutics
Ronald Ellis, Adam Weiss
doaj   +1 more source

Prospective estimation of water equivalent diameter and SSDE using 3D landmark CT scans. [PDF]

J Appl Clin Med Phys
Hernandez AM, Yoon S, Corwin MT, Diaz ES, Ghasemiesfe A, McKenney SE, Boone JM.   +6 more
europepmc   +1 more source

Single‐cell DNA methylation profiling: Technologies, computation, and applications in precision oncology

Molecular Oncology, EarlyView.
Single‐cell DNA methylation (scDNAme) profiling maps epimutational clonal evolution, revealing mechanisms of malignancy and therapeutic resistance across diverse cancer types. By providing a high‐resolution landscape of intratumoral heterogeneity, these technologies empower precise patient stratification, guide the development of enhanced ...
Ik Soo Kim
wiley   +1 more source

Human vaccines and immunotherapeutics: News December 2024

Human Vaccines & Immunotherapeutics
Ronald Ellis, Adam Weiss
doaj   +1 more source

Biodistribution and dosimetry of the carbon-11 labelled PARP1-selective PET radiopharmaceutical [¹¹C]AZ14193391. [PDF]

EJNMMI Res
Törnblom A, He C, Bolin M, Tzortzakakis A, Fernebro J, Li C, Fridsten S, Altena R, Axelsson R, Siikanen J, Hindorf C.   +10 more
europepmc   +1 more source

CEACAM1 participation in breast cancer progression

Molecular Oncology, EarlyView.
In invasive breast cancer (BC), CEACAM1 shifts from an apical to a uniform membranous/cytoplasmic pattern, or is lost, as tumors dedifferentiate, inversely tracking the Ki‐67 proliferative index. In MCF‐7 cells, only CEACAM1‐4L suppresses proliferation, repressing cell cycle and growth factor genes.
Mykola Lyndin, Irina Kube‐Golovin, Anatolii Romaniuk, Gunther Wennemuth   +3 more
wiley   +1 more source

Hospital System Acquisition of Physician Practices.

JAMA Netw Open
Young GJ, Duran D, Ratto I, Senier L, Post B.   +4 more
europepmc   +1 more source